Back to Search Start Over

1306TiPILLUMINATE 301: A randomized phase III comparison of IMO-2125 with ipilimumab (ipi) versus ipi alone in subjects with anti PD 1 refractory melanoma.

Authors :
Ascierto, P A
Arenberger, P
Atkinson, V G
Hansson, J
Kapiteijn, E
Loquai, C
Negrier, S
Shaw, H M
Tarhini, A
Walker, J
Source :
Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Publication Year :
2018

Subjects

Subjects :
*MELANOMA
*ACADEMIC medical centers

Details

Language :
English
ISSN :
09237534
Volume :
29
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
133286857
Full Text :
https://doi.org/10.1093/annonc/mdy289.062
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details